Transdermal iontophoretic delivery of insulin using a photoetched microdevice

Journal of Controlled Release

Volumn 43, Issue 2-3, 1997, Pages 139-149

  Haga, Makoto ^a   Akatani, Mieko ^a   Kikuchi, Jun ^a   Ueno, Yuji ^a   Hayashi, Masahiro ^a  

^a TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Diabetic rat; Hypoglycemic effect; Insulin; Photoetched microdevice; Transdermal iontophoresis

Indexed keywords

CARBOXYFLUORESCEIN; INSULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; IONTOPHORESIS; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; RAT; SKIN CONDUCTANCE; SKIN PENETRATION; STRATUM CORNEUM; STREPTOZOCIN DIABETES; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0031060296     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01476-9     Document Type: Article

References (23)

1. B. Kari, Control of blood glucose levels in alloxan-diabetic rabbits by iontophoresis of insulin. Diabetes 35 (1986) 217-221.
2. J.C. Liu, Y. Sun, O. Siddiqui, Y.W. Chien, W.M. Shi and J. Li, Blood glucose control in diabetic rats by transdermal iontophoretic delivery of insulin. Int. J. Pharm. 44 (1988) 197-204.
3. Y.W. Chien, O. Siddiqui, Y. Sun, W.M. Shi and J.C. Liu, Transdermal iontophoretic delivery of therapeutic peptides/proteins. I. Insulin. Ann. NY Acad. Sci. 507 (1987) 32-51.
4. R.R. Burnette and D. Marrero, Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J. Pharm. Sci. 75 (1986) 738-743.
5. P.G. Green, R.S. Hinz, A. Kim, F.C. Szoka, Jr. and R.H. Guy, Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm. Res. 8 (1991) 1121-1127.
6. D.B. Bommannan, J. Tamada, L. Leung and R.O. Potts, Effect of electroporation on transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH) in vitro. Pharm. Res. 11 (1994) 1809-1814.
7. M.C. Heit, N.A. Monteiro-Riviere, F.L. Jayes and J.E. Riviere, Transdermal iontophoretic delivery of luteinizing hormone releasing hormone (LHRH): effect of repeated administration. Pharm. Res. 11 (1994) 1000-1003.
8. M.C. Heit, P.L. Williams, F.L. Jayes, S.K. Chang and J.E. Riviere, Transdermal inotophoretic peptide delivery: in vitro and in vivo studies with luteinizing hormone releasing hormone. J. Pharm. Sci. 82 (1993) 240-243.
9. D.T.W. Lau, J.W. Sharkey, L. Petryk, F.A. Mancuso, Z. Yu and F.L.S. Tse, Effect of current magnitude and drug concentration on iontophoretic delivery of octreotide acetate (Sandostatin®) in the rabbit. Pharm. Res. 11 (1994) 1742-1746.
10. A.J. Hoogstraate, V. Srinivasan, S.M. Sims and W.I. Higuchi, Iontophoretic enhancement of peptides: behavior of leuprolide versus model permeants. J. Control. Release 31 (1994) 41-47.
11. P. Lelawongs, J.C. Liu, O. Siddiqui and Y.W. Chien, Transdermal iontophoretic delivery of arginine-vasopressin (I): physicochemical consideration. Int. J. Pharm. 56 (1989) 13-22.
12. K. Morimoto, Y. Iwakura, M. Miyazaki and E. Nakatani, Effects of proteolytic enzyme inhibitors of enhancement of transdermal iontophoretic delivery of vasopressin and an analogue in rats. Int. J. Pharm. 81 (1992) 119-125.
13. S. Thysman, C. Hanchard and V. Préat, Human calcitonin delivery in rats by iontophoresis. J. Pharm. Pharmacol. 46 (1994) 725-730.
14. M. Haga, Y. Ueno and M. Hayashi, Development of practical iontophoretic devices using a photoetching technique, Int. Symp. Deliv. Protein Drugs - The Next 10 Years, Kyoto, 1993, pp. 73-74.
15. + permeability of excised nude mouse skin. J. Pharm. Sci. 77 (1988) 492-497.
16. B.L. Shapiro, T.V. Pence, W.J. Warwick, Insulin iontophoresis in cystic fibrosis (33858). Proc. Soc. Exp. Biol. Med. 149 (1975) 592-593.
17. J. Brange, U. Ribel, J.F. Hansen, G. Dodsen, M.T. Hansen, S. Havelund, S.G. Melberg, F. Norris, K. Norris, L. Snel, A.R. Sørensen and H.O. Voigt, Monomeric insulins obtained by protein engineering and their medical implications. Nature 333 (1988) 679-682.
18. Y. Yamamoto and T. Yamamoto, Dispersion and correlation of the parameters for skin impedance. Med. Biol. Eng. Comp. 16 (1978) 592-594.
19. M.J. Pikal and S. Shah, Study of the mechanisms of flux enhancement through hairless mouse skin by pulsed DC iontophoresis. Pharm. Res. 8 (1991) 365-369.
20. P. Knoblauch and F. Moll, In vitro pulsatile and continuous transdermal delivery of buserelin by iontophoresis. J. Control. Release 26 (1993) 203-212.
21. V. Préat and S. Thysman, Transdermal iontophoretic delivery of sufentanil. Int. J. Pharm. 96 (1993) 189-196.
22. F. Hueber, R. Yuan, E. Aspe-Carranza and R.H. Guy, The effect of current profile on iontophoretic drug delivery across the skin. In: Proceedings of the 21st International Symposium on Controlled Release of Bioactive Materials, Nice, France, 1994, pp. 381-382.
23. M. Gicquel, P. Millot, H. Hueber and E. Teilland, Human skin tolerance study of 4 different iontophoretic currents: effects of waveforms and frequency. In: Proceedings of the 21st International Symposium on Controlled Release of Bioactive Materials, Nice, France, 1994, pp. 363-364.